CN Stock MarketDetailed Quotes
000813 Dezhan Healthcare
- 2.37
- -0.03-1.25%
Market Closed Jul 19 15:00 CST
5.13BMarket Cap79.00P/E (TTM)
2.44High2.36Low262.06KlotVolume2.41Open2.40Pre Close62.75MTurnover1.21%Turnover Ratio62.37P/E (Static)2.16BShares4.7052wk High0.98P/B5.13BFloat Cap2.0652wk Low2.64Limit Up2.16BShs Float15.29Historical High2.16Limit Down3.33%Amplitude0.69Historical Low--Dividend TTM2.39Avg Price135.95KlotAsk--Div YieldTTM100Lot Size121.66KlotBid
Dezhan Healthcare Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -25.09%101.25M | -12.75%498.09M | -19.56%335.14M | -27.36%220.81M | -29.90%135.16M | -22.28%570.86M | -18.77%416.62M | -22.41%304M | -8.87%192.82M | -23.72%734.48M |
| Operating revenue | -25.09%101.25M | -12.75%498.09M | -19.56%335.14M | -27.36%220.81M | -29.90%135.16M | -22.28%570.86M | -18.77%416.62M | -22.41%304M | -8.87%192.82M | -23.72%734.48M |
| Other operating revenue | ---- | 1,442.93%1.72M | ---- | 87,477.21%801.17K | ---- | -97.62%111.32K | ---- | -99.98%914.82 | ---- | 234.77%4.67M |
| Total operating cost | -13.21%106.51M | -16.69%468.29M | -13.22%328.97M | -21.18%207.6M | -19.06%122.73M | -9.35%562.11M | -8.50%379.08M | -7.59%263.38M | 5.85%151.62M | -12.58%620.1M |
| Operating cost | -15.78%49.03M | -19.11%205.54M | -20.31%136.43M | -26.17%85.74M | -24.72%58.22M | 4.76%254.11M | -0.44%171.21M | -5.83%116.13M | 20.56%77.34M | -17.07%242.56M |
| Operating tax surcharges | -21.32%3.08M | 21.27%11.47M | 22.66%9.07M | -1.31%5.89M | 35.43%3.92M | -23.12%9.46M | -28.50%7.4M | -20.55%5.97M | -37.41%2.89M | -29.14%12.3M |
| Operating expense | -35.18%16.89M | -40.57%91.6M | -34.33%65.69M | -41.55%41.5M | -28.61%26.05M | -18.85%154.13M | -9.04%100.03M | 1.12%70.99M | 7.07%36.49M | -7.77%189.94M |
| Administration expense | 4.61%43.56M | 13.89%173.56M | 12.81%126.86M | 1.14%77.85M | 11.74%41.64M | -1.85%152.4M | 6.45%112.46M | 3.80%76.97M | 13.55%37.26M | 0.05%155.27M |
| Financial expense | 10.96%-16.92M | -9.24%-64.97M | -1.88%-46.77M | -2.18%-29.63M | -45.41%-19M | -26.48%-59.47M | -29.14%-45.91M | -20.39%-29M | -16.43%-13.07M | -165.44%-47.02M |
| -Interest expense (Financial expense) | -45.25%97.33K | -48.60%365.89K | 18.75%302.92K | 22.35%235.05K | 133.19%177.77K | 8.91%711.8K | 81.87%255.09K | -13.44%192.11K | --76.24K | 252.09%653.56K |
| -Interest Income (Financial expense) | 8.08%-17.05M | -0.59%-68.01M | -3.78%-51.14M | -10.27%-34.45M | -31.41%-18.55M | -28.23%-67.61M | -24.41%-49.28M | -15.30%-31.24M | -12.02%-14.11M | -123.35%-52.72M |
| Research and development | -8.65%10.88M | -0.76%51.1M | 11.18%37.69M | 17.65%26.26M | 11.12%11.91M | -23.22%51.49M | -34.73%33.9M | -34.18%22.32M | -43.00%10.72M | 19.64%67.06M |
| Credit Impairment Loss | -672.62%-10.61M | -50.95%-12.57M | -390.49%-9.78M | -265.71%-7.56M | -149.88%-1.37M | 94.82%-8.33M | 78.11%-1.99M | 67.85%-2.07M | -226.58%-549.61K | -288,490.68%-160.9M |
| Asset Impairment Loss | -110.39%-23.41K | 84.54%-21.99M | ---14.16M | -47.15%-15.73M | 102.11%225.41K | -362.41%-142.2M | ---- | -221,481.01%-10.69M | ---10.69M | -1,211.14%-30.75M |
| Other net revenue | -137.89%-11.36M | 139.53%50.43M | 37.58%40.46M | -249.59%-29.95M | 60.53%-4.78M | 15.83%-127.57M | 5.43%29.41M | 224.50%20.02M | -596.78%-12.1M | -253.23%-151.57M |
| Invest income | 59.87%-1.78M | 318.40%80.31M | 111.37%62.15M | -127.06%-8.47M | -136.95%-4.42M | -40.19%19.19M | -2.60%29.41M | 369.11%31.29M | -278.51%-1.87M | -66.05%32.09M |
| -Including: Investment income associates | 59.87%-1.78M | -240.78%-47.48M | -341.20%-16.42M | -361.50%-8.47M | -96.52%-4.42M | -227.16%-13.93M | 25.88%-3.72M | 18.25%-1.83M | -167.47%-2.25M | 35.91%-4.26M |
| Asset deal income | ---- | -110.44%-34.11K | -101.34%-1.07K | ---- | ---- | 1,482.85%326.74K | 287.80%80.05K | 287.80%80.05K | 576.79%69.21K | 406.97%20.64K |
| Other revenue | 31.80%1.05M | 37.37%4.71M | 17.05%2.24M | 29.31%1.82M | -15.20%796.39K | -56.95%3.43M | -71.79%1.92M | -76.68%1.41M | -48.49%939.17K | 38.60%7.97M |
| Operating profit | -317.11%-16.62M | 167.52%80.22M | -30.35%46.63M | -127.61%-16.74M | -73.68%7.66M | -219.49%-118.82M | -47.06%66.95M | -46.33%60.63M | -58.90%29.09M | -110.55%-37.19M |
| Add:Non operating Income | 256.67%11.44K | 368.70%3M | 378.02%2.98M | 61.81%155.93K | -47.58%3.21K | -13.35%640.52K | -6.71%623.76K | 10.44%96.37K | -92.71%6.12K | -38.75%739.19K |
| Less:Non operating expense | 85.95%873.65K | -52.25%1.39M | -49.28%1.16M | -30.39%639.19K | 119.78%469.82K | 342.34%2.9M | 1,342.78%2.29M | 542.75%918.23K | 119.10%213.77K | -85.21%655.74K |
| Total profit | -343.19%-17.49M | 167.59%81.84M | -25.78%48.45M | -128.80%-17.22M | -75.11%7.19M | -226.30%-121.08M | -48.58%65.29M | -47.03%59.81M | -59.19%28.89M | -110.62%-37.11M |
| Less:Income tax cost | -37.52%4.13M | -14.76%27.6M | -57.81%10.04M | -52.47%9.1M | 10.92%6.61M | -45.21%32.38M | 7.55%23.79M | -16.09%19.14M | -53.38%5.96M | -21.85%59.09M |
| Net profit | SL-21.61M | FLtoP54.24M | -7.42%38.42M | SL-26.32M | -97.46%582.61K | FPtoL-153.46M | -60.42%41.5M | -54.86%40.67M | -60.46%22.93M | SL-96.2M |
| Net profit from continuing operation | -3,809.85%-21.61M | 135.35%54.24M | -7.42%38.42M | -164.73%-26.32M | -97.46%582.61K | -59.52%-153.46M | -60.42%41.5M | -54.86%40.67M | -60.46%22.93M | -135.16%-96.2M |
| Less:Minority Profit | -276.64%-4.81M | 72.70%-29.07M | 6.81%-22.95M | 24.49%-18.76M | 83.01%-1.28M | -175.79%-106.51M | -25.52%-24.63M | -98.95%-24.84M | -21.51%-7.52M | -254.21%-38.62M |
| Net profit of parent company owners | -1,003.80%-16.81M | 277.45%83.31M | -7.20%61.37M | -111.55%-7.56M | -93.89%1.86M | 18.46%-46.95M | -46.88%66.12M | -36.14%65.51M | -52.56%30.45M | -120.24%-57.58M |
| Earning per share | ||||||||||
| Basic earning per share | -1,075.00%-0.0078 | 280.19%0.0382 | -5.07%0.0281 | -111.60%-0.0034 | -94.12%0.0008 | 17.51%-0.0212 | -46.76%0.0296 | -36.03%0.0293 | -52.61%0.0136 | -120.05%-0.0257 |
| Diluted earning per share | -1,075.00%-0.0078 | 280.19%0.0382 | -5.07%0.0281 | -111.60%-0.0034 | -94.12%0.0008 | 17.51%-0.0212 | -46.76%0.0296 | -36.03%0.0293 | -52.61%0.0136 | -120.05%-0.0257 |
| Other composite income | -2.13M | 0 | ||||||||
| Other composite income of parent company owners | ---- | ---2.13M | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Total composite income | -3,809.85%-21.61M | 133.96%52.12M | -7.42%38.42M | -164.73%-26.32M | -97.46%582.61K | -59.52%-153.46M | -60.42%41.5M | -54.86%40.67M | -60.46%22.93M | -135.16%-96.2M |
| Total composite income of parent company owners | -1,003.80%-16.81M | 272.92%81.19M | -7.20%61.37M | -111.55%-7.56M | -93.89%1.86M | 18.46%-46.95M | -46.88%66.12M | -36.14%65.51M | -52.56%30.45M | -120.24%-57.58M |
| Total composite income of minority owners | -276.64%-4.81M | 72.70%-29.07M | 6.81%-22.95M | 24.49%-18.76M | 83.01%-1.28M | -175.79%-106.51M | -25.52%-24.63M | -98.95%-24.84M | -21.51%-7.52M | -254.21%-38.62M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | ZTE Finance Guanghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daishin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg